Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A London

Showing results (331-340 of 361) with videos related to

Pageof 37
Sort By:
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Carvedilol Exerts Cardioprotective Effects Against Doxorubicin Toxicity via Autophagy Modulation and Energetics RestorationAsma Boukhalfa, Pei-Tsz Shin, Dawn M Meola, et al.
Physical Review. E|December 17, 2020
Benchmarking boron carbide equation of state using computation and experimentShuai Zhang, Michelle C Marshall, Lin H Yang, et al.
Plos One|February 8, 2014
Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I studyCheryl A London, Luis Feo Bernabe, Sandra Barnard, et al.
Journal of the American Veterinary Medical Association|May 1, 1996
Evaluation of dogs and cats with tumors of the ear canal: 145 cases (1978-1992)C A London, R R Dubilzeig, D M Vail, et al.
Frontiers in Veterinary Science|November 29, 2023
Cathepsin W, T-cell receptor-associated transmembrane adapter 1, lymphotactin and killer cell lectin like receptor K1 are sensitive and specific RNA biomarkers of canine epitheliotropic lymphomaJadesola Temitope Olayinka, Akanksha Nagarkar, Diana Junyue Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excisionCheryl A London, Phyllis B Malpas, Stacey L Wood-Follis, et al.
Plos One|July 28, 2017
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcomaPeter Y Yu, Heather L Gardner, Ryan Roberts, et al.
Molecular Cancer Therapeutics|January 25, 2023
Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood SarcomaTerry J Shackleford, Seethalakshmi Hariharan, Angelina V Vaseva, et al.
The Review of Scientific Instruments|November 7, 2012
X-ray bang-time and fusion reaction history at picosecond resolution using RadOptic detectionS P Vernon, M E Lowry, K L Baker, et al.
Physical Review Letters|May 16, 2007
Subnanometer-scale measurements of the interaction of ultrafast soft x-ray free-electron-laser pulses with matterStefan P Hau-Riege, Henry N Chapman, Jacek Krzywinski, et al.
Pageof 37

Showing results (331-340 of 361) with videos related to

Sort By:
Pageof 37
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Carvedilol Exerts Cardioprotective Effects Against Doxorubicin Toxicity via Autophagy Modulation and Energetics RestorationAsma Boukhalfa, Pei-Tsz Shin, Dawn M Meola, et al.
Physical Review. E|December 17, 2020
Benchmarking boron carbide equation of state using computation and experimentShuai Zhang, Michelle C Marshall, Lin H Yang, et al.
Plos One|February 8, 2014
Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I studyCheryl A London, Luis Feo Bernabe, Sandra Barnard, et al.
Journal of the American Veterinary Medical Association|May 1, 1996
Evaluation of dogs and cats with tumors of the ear canal: 145 cases (1978-1992)C A London, R R Dubilzeig, D M Vail, et al.
Frontiers in Veterinary Science|November 29, 2023
Cathepsin W, T-cell receptor-associated transmembrane adapter 1, lymphotactin and killer cell lectin like receptor K1 are sensitive and specific RNA biomarkers of canine epitheliotropic lymphomaJadesola Temitope Olayinka, Akanksha Nagarkar, Diana Junyue Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Multi-center, placebo-controlled, double-blind, randomized study of oral toceranib phosphate (SU11654), a receptor tyrosine kinase inhibitor, for the treatment of dogs with recurrent (either local or distant) mast cell tumor following surgical excisionCheryl A London, Phyllis B Malpas, Stacey L Wood-Follis, et al.
Plos One|July 28, 2017
Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcomaPeter Y Yu, Heather L Gardner, Ryan Roberts, et al.
Molecular Cancer Therapeutics|January 25, 2023
Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood SarcomaTerry J Shackleford, Seethalakshmi Hariharan, Angelina V Vaseva, et al.
The Review of Scientific Instruments|November 7, 2012
X-ray bang-time and fusion reaction history at picosecond resolution using RadOptic detectionS P Vernon, M E Lowry, K L Baker, et al.
Physical Review Letters|May 16, 2007
Subnanometer-scale measurements of the interaction of ultrafast soft x-ray free-electron-laser pulses with matterStefan P Hau-Riege, Henry N Chapman, Jacek Krzywinski, et al.
Pageof 37